Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

Walmart has already updated its social media accounts to reflect the new logo and wordmark, leading to critical and confused reactions from users. One shared the “before and after” images of ...

International drug giant GSK plc is moving its vaccine R&D and infectious disease teams to Cambridge from Maryland, and plans to expand its footprint here.

Slaughter and May has elected David Johnson as its next managing partner, succeeding Deborah Finkler in the role. The change ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

DeepSeek's friendly whale hearkens back to a more playful era of tech branding—and it might just be the disruptor the AI ...

GSK's vaccine for shingles prevention. This new syringe presentation is designed to simplify the administration process for healthcare providers by eliminating the need to mix a powder and liquid ...

Scientists are working to create a new cancer vaccine that ... the deep knowledge of Oxford and GSK scientists. By exploring precancer biology and building on GSK’s expertise in the science ...

5 This European regulatory review follows the file acceptance by the US FDA on 8 January 2025 for the new prefilled syringe presentation, continuing GSK’s commitment to providing solutions to ...

An experimental muscle-building drug helped people with obesity taking Wegovy preserve significantly more lean mass than Wegovy alone in a 16-week trial, the drug’s developer, Veru, said Monday. Trial ...

New shares at such a low price could add value to my existing holding in GSK. But I need to check that there is value in the stock. Such a fall could also indicate that the company is simply worth ...